{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:23:53Z","timestamp":1782393833065,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00108-021-00959-5","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T08:30:19Z","timestamp":1613291419000},"page":"326-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Allergische Reaktionen auf COVID-19-Impfstoffe \u2013 Evidenz und praxisorientiertes Vorgehen","Allergic reactions to COVID-19 vaccines: evidence and practice-oriented approach"],"prefix":"10.1007","volume":"62","author":[{"given":"L.","family":"Klimek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eckrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Casper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"959_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","author":"FP Polack","year":"2020","unstructured":"Polack\u00a0FP, Thomas\u00a0SJ, Kitchin\u00a0N, Absalon\u00a0J, Gurtman\u00a0A, Lockhart\u00a0S et\u00a0al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"Engl J Med"},{"issue":"20","key":"959_CR2","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson\u00a0LA, Anderson\u00a0EJ, Rouphael\u00a0NG, Roberts\u00a0PC, Makhene\u00a0M, Coler\u00a0RN et al (2020) An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N\u00a0Engl J Med 383(20):1920\u20131931","journal-title":"N Engl J Med"},{"key":"959_CR3","doi-asserted-by":"crossref","unstructured":"Klimek\u00a0LNN, Cabanillas\u00a0B, Jutel\u00a0M, Bousquet\u00a0J, Akdis\u00a0CA (2021) Potential allergenic components of the mRNA-1273 vaccine for COVID-19: possible roles for polyethlene glycol and IgG-mediated complement activation. Allergy (in press)","DOI":"10.22541\/au.160952242.21038379\/v1"},{"key":"959_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-020-00160-4","author":"LNN Klimek","year":"2020","unstructured":"Klimek\u00a0LNN, Hamelmann\u00a0E et\u00a0al (2020) Severe allergic reactions after COVID-19-Vaccination with the Pfizer\/BioNTech Vaccine in Great Britain and USA Position Statement of the German allergological Societies AeDA, DGAKI and GPA. Allergo J Int. https:\/\/doi.org\/10.1007\/s40629-020-00160-4 (in preparation)","journal-title":"Allergo J Int"},{"issue":"49","key":"959_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.15585\/mmwr.mm6949e1","volume":"69","author":"K Dooling","year":"2020","unstructured":"Dooling\u00a0K, McClung\u00a0N, Chamberland\u00a0M, Marin\u00a0M, Wallace\u00a0M, Bell\u00a0BP et al (2020) The advisory committee on immunization practices\u2019 interim recommendation for allocating initial supplies of COVID-19 vaccine\u2014United States, 2020. MMWR Morb Mortal Wkly Rep 69(49):1857\u20131859","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"959_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/nano10020190","author":"CT Inglut","year":"2020","unstructured":"Inglut\u00a0CT, Sorrin\u00a0AJ, Kuruppu\u00a0T, Vig\u00a0S, Cicalo\u00a0J, Ahmad\u00a0H et\u00a0al (2020) Immunological and toxicological considerations for the design of liposomes. Nanomaterials. https:\/\/doi.org\/10.3390\/nano10020190","journal-title":"Nanomaterials"},{"issue":"1","key":"959_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","volume":"1066","author":"TM Allen","year":"1991","unstructured":"Allen\u00a0TM, Hansen\u00a0C, Martin\u00a0F, Redemann\u00a0C, Yau-Young\u00a0A (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066(1):29\u201336","journal-title":"Biochim Biophys Acta"},{"key":"959_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/all.14726","author":"LJM Klimek","year":"2020","unstructured":"Klimek\u00a0LJM, Akdis\u00a0C (2020) ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines\u2014an EAACI-ARIA Position Paper. Allergy. https:\/\/doi.org\/10.1111\/all.14726","journal-title":"Allergy"},{"key":"959_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.029","author":"P Sellaturay","year":"2020","unstructured":"Sellaturay\u00a0P, Nasser\u00a0S, Ewan\u00a0P (2020) Polyethylene glycol-induced systemic allergic reactions (anaphylaxis). J\u00a0Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.029","journal-title":"Allergy"},{"issue":"5","key":"959_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","volume":"7","author":"CA Stone","year":"2018","unstructured":"Stone\u00a0CA, Liu\u00a0Y, Relling\u00a0MV, Krantz\u00a0MS, Pratt\u00a0AL, Abreo\u00a0A et\u00a0al (2018) Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized. J\u00a0Allergy Clin Immunol Pract 7(5):1533\u20131540.e8","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"959_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/cea.12760","volume":"46","author":"E Wenande","year":"2016","unstructured":"Wenande\u00a0E, Garvey\u00a0LH (2016) Immediate-type hypersensitivity to polyethylene glycols: a\u00a0review. Clin Exp Allergy 46(7):907\u2013922","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"959_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13223-016-0172-7","volume":"12","author":"K Wylon","year":"2016","unstructured":"Wylon\u00a0K, D\u00f6lle\u00a0S, Worm\u00a0M (2016) Polyethylene glycol as a\u00a0cause of anaphylaxis. Allergy Asthma Clin Immunol 12(1):67","journal-title":"Allergy Asthma Clin Immunol"},{"key":"959_CR13","doi-asserted-by":"crossref","unstructured":"Krantz\u00a0MLY, Phillips\u00a0EJ, Stone\u00a0CA (2020) COVID-19 vaccine anaphylaxis: PEG or not? Allergy (in press)","DOI":"10.1111\/all.14722"},{"issue":"4","key":"959_CR14","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jaip.2019.12.041","volume":"8","author":"MS Krantz","year":"2020","unstructured":"Krantz\u00a0MS, Liu\u00a0Y, Phillips\u00a0EJ, Stone\u00a0CA Jr. (2020) Anaphylaxis to PEGylated liposomal echocardiogram contrast in a\u00a0patient with IgE-mediated macrogol allergy. J\u00a0Allergy Clin Immunol Pract 8(4):1416\u20131419e3","journal-title":"J Allergy Clin Immunol Pract"},{"key":"959_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","volume":"61","author":"J Szebeni","year":"2014","unstructured":"Szebeni\u00a0J (2014) Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 61:163\u2013173","journal-title":"Mol Immunol"},{"key":"959_CR16","unstructured":"Ring\u00a0J, Beyer\u00a0K, Biedermann\u00a0T, Bircher\u00a0A, Fischer\u00a0M, Fuchs\u00a0T et\u00a0al (2021) Guidelines (S2) to acute therapy and management of anaphylaxis\u2014update 2021. Allergo J Int (in press)"},{"issue":"7","key":"959_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s15007-020-2618-y","volume":"29","author":"L Klimek","year":"2020","unstructured":"Klimek\u00a0L, Worm\u00a0M, Lange\u00a0L, Beyer\u00a0K, Rietschel\u00a0E, Vogelberg\u00a0C et al (2020) Management von Anaphylaxiegef\u00e4hrdeten Patienten w\u00e4hrend der Covid-19-Pandemie. Allergo\u00a0J 29(7):16\u201326","journal-title":"Allergo J"},{"key":"959_CR18","doi-asserted-by":"crossref","unstructured":"CDC (2021) COVID-19 Response Team, FDA\u2014Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine\u2014United States, December 14\u201323, 2020: Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7002e1.htm. Zugegriffen: 6.\u00a0Jan. 2021 (updated 06.01.2021)","DOI":"10.15585\/mmwr.mm7002e1"},{"issue":"2","key":"959_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","volume":"140","author":"M Castells","year":"2017","unstructured":"Castells\u00a0M (2017) Diagnosis and management of anaphylaxis in precision medicine. J\u00a0Allergy Clin Immunol 140(2):321\u2013333","journal-title":"J Allergy Clin Immunol"},{"key":"959_CR20","unstructured":"Klimek\u00a0L, Bergmann\u00a0KC, Brehler\u00a0R, Pf\u00fctzner\u00a0W, Worm\u00a0M, Hartmann\u00a0K et\u00a0al (2021) Allergologische Diagnostik und Therapien bei COVID-19 Impfungen: Praktische Handlungsempfehlungen. Empfehlungen von AeDA, DGAKI und GPA. Allergo\u00a0J (in press)"},{"issue":"12","key":"959_CR21","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1111\/bcp.14112","volume":"85","author":"CA Stone Jr.","year":"2019","unstructured":"Stone\u00a0CA Jr., Rukasin\u00a0CRF, Beachkofsky\u00a0TM, Phillips\u00a0EJ (2019) Immune-mediated adverse reactions to vaccines. Br J Clin Pharmacol 85(12):2694\u20132706","journal-title":"Br J Clin Pharmacol"},{"issue":"7830","key":"959_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer\u00a0F (2020) SARS-CoV\u20112 vaccines in development. Nature 586(7830):516\u2013527","journal-title":"Nature"},{"issue":"3","key":"959_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s15007-020-2538-x","volume":"29","author":"T Jakob","year":"2020","unstructured":"Jakob\u00a0T, Klimek\u00a0L (2020) Allergologie in Zeiten von Covid-19. Allergo\u00a0J 29(3):3","journal-title":"Allergo J"},{"issue":"3","key":"959_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s15007-020-2539-9","volume":"29","author":"L Klimek","year":"2020","unstructured":"Klimek\u00a0L, Pfaar\u00a0O, Worm\u00a0M, Bergmann\u00a0K\u2011C, Bieber\u00a0T, Buhl\u00a0R et al (2020) Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie a, b, c. Allergo\u00a0J 29(3):17\u201325","journal-title":"Allergo J"},{"issue":"7","key":"959_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5414\/ALX02166","volume":"43","author":"L Klimek","year":"2020","unstructured":"Klimek\u00a0L, Pfaar\u00a0O, Worm\u00a0M (2020) Anwendung von Biologika bei allergischen und Typ-2-entz\u00fcndlichen Erkrankungen in der aktuellen COVID-19-Pandemie \u2013 ein Positionspapier von AeDA, DGAKI, GPA, \u00d6GAI, LGAI, \u00d6GP, ARIA und EAACI. Use of biologicals in allergic and type\u20112 inflammatory diseases in times of the current COVID-19 pandemic\u2014Position paper of AeDA, DGAKI, GPA, \u00d6GAI, LGAI, \u00d6GP, ARIA und EAACI. Allergologie 43(7):255","journal-title":"Allergologie"},{"issue":"36","key":"959_CR26","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","volume":"36","author":"GA Poland","year":"2018","unstructured":"Poland\u00a0GA, Ovsyannikova\u00a0IG, Kennedy\u00a0RB (2018) Personalized vaccinology: a review. Vaccine 36(36):5350\u20135357","journal-title":"Vaccine"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-021-00959-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-00959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:52:32Z","timestamp":1671263552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-021-00959-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-00959-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"20 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Klimek, J.\u00a0Eckrich, J.\u00a0Hagemann, I.\u00a0Casper und J.\u00a0Huppertz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}